|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Acolbifene>> Market Analysis Reports |
Market Analysis Reports of Acolbifene |
|
Acolbifene (CAS 182167-02-8) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Acolbifene Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of ACOLBIFENE (CAS 151533-34-5) December 2024 Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2018 Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2018 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2018, provides an ... Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H2 2017 Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H2 2017 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H2 2017, provides an ... Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H2 2018 Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H2 2018 SUMMARY Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or ... Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H2 2018 Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H2 2018 SUMMARY Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Estrogen receptor ... Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H1 2018 Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H1 2018 SUMMARY According to the recently published report 'Estrogen Receptor - Pipeline Review, H1 2018'; Estrogen ... Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H1 2018 Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H1 2018 SUMMARY Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) pipeline Target ... Estrogen Receptor Beta - Pipeline Review, H2 2020 Estrogen Receptor Beta - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Estrogen Receptor Beta - Pipeline Review, H2 2020'; Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) ... Estrogen Receptor - Pipeline Review, H2 2019 Estrogen Receptor - Pipeline Review, H2 2019 SUMMARY Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Estrogen receptor alpha (ERA) is a nuclear receptor that is activated by the sex ... Estrogen Receptor Beta - Pipeline Review, H1 2020 Estrogen Receptor Beta - Pipeline Review, H1 2020 SUMMARY Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) pipeline Target constitutes close to 20 molecules. Out of which approximately 14 molecules are ... Vasomotor Symptoms - Pipeline Insight, 2021 ... Products Donesta Osanetant Q-122 Elinzanetant Acolbifene + prasterone Fezolinetant Elismetrep Filgrastim Estrogen Receptor Beta - Drugs In Development, 2021 Estrogen Receptor Beta - Drugs In Development, 2021 SUMMARY According to the recently published report 'Estrogen Receptor Beta - Drugs In Development, 2021'; Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2 ... Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Estrogen Receptor Beta (ER Beta ... |